SCHEDULE: Solas Capital Management Discloses 9.9% Stake in Modular Medical

Solas Capital Management, LLC and Frederick Tucker Golden have reported beneficial ownership of approximately 9.99% of Modular Medical, Inc.'s common stock, primarily through investment funds and warrants.

Summary

• Solas Capital Management, LLC, an investment adviser, and its Portfolio Manager, Frederick Tucker Golden, have filed a Schedule 13G, indicating beneficial ownership of 552,171 shares of Modular Medical, Inc. common stock.
• This holding represents approximately 9.99% of the company's outstanding common stock.
• The reported shares include 438,095 directly held shares and 114,076 shares issuable upon the exercise of warrants.
• The filing clarifies that the reporting persons disclaim beneficial ownership over securities held by the funds, and the filing does not imply control.
• The percentage ownership calculation considers outstanding shares and shares issuable from warrants, with a blocker provision limiting exercise to maintain below 9.99% ownership.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as neutral to slightly positive, indicating a significant but not controlling stake. The disclosure itself is routine for institutional investors crossing a reporting threshold.

Positives

• Institutional investor Solas Capital Management has taken a significant stake, signaling potential confidence in Modular Medical's prospects.
• The stake of 9.99% is substantial and could lead to increased liquidity or strategic engagement.
• The inclusion of exercisable warrants suggests a belief in the potential upside of the stock.

Negatives

• The filing does not provide any new operational or financial performance data for Modular Medical, Inc.
• The blocker provision on warrants indicates a deliberate strategy to avoid exceeding a specific ownership threshold, potentially limiting future upside for the reporting persons or signaling caution.

Risks

• The primary risk is that the reporting persons' investment thesis may not materialize, leading to a potential sale of shares and downward pressure on the stock price.
• Future exercise of warrants could dilute existing shareholders if not managed carefully by the company.
• The blocker provision on warrants limits the reporting persons' ability to increase their stake beyond 9.99% without further action, potentially capping their influence or investment potential.

Future Outlook

The filing itself does not contain forward-looking statements or guidance from Modular Medical, Inc. It solely reports on the beneficial ownership of securities by Solas Capital Management, LLC and Frederick Tucker Golden.

Management Comments

• Solas Capital Management, LLC is an investment adviser that is registered under the Investment Advisers Act of 1940.
• Solas Capital Management, LLC, which serves as the investment manager to two private funds (the "Funds") and as sub-adviser to another private fund (the "Other Fund"), which hold securities for the benefit of their investors, and Mr. Frederick Tucker Golden, as Portfolio Manager of Solas Capital Management, LLC, with the power to exercise investment and voting discretion, may be deemed to be the beneficial owners of all shares of Common Stock held by the Funds and by the Other Fund.
• Pursuant to Rule 13d-4 under the Securities Exchange Act of 1934, as amended, each of the Funds and the Other Fund expressly disclaims beneficial ownership over any of the securities reported in this statement, and the filing of this statement shall not be construed as an admission that any of the Funds and the Other Fund are the beneficial owner of any of the securities reported herein.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and investment funds when their ownership stake in a public company crosses a reporting threshold (typically 5%). This filing indicates Solas Capital Management has reached a significant ownership level in Modular Medical, Inc., which is typical in the healthcare technology sector where strategic stakes can be taken by specialized funds.

Stakeholder Impact

• Shareholders: The increased institutional interest may be viewed positively, but the significant stake and potential warrant exercise could also lead to dilution concerns or shifts in control dynamics.
• Management: May face increased scrutiny or engagement from a significant institutional holder.
• Creditors: No direct impact indicated by this filing.

Next Steps

• Solas Capital Management, LLC and Frederick Tucker Golden will continue to monitor their investment in Modular Medical, Inc.
• Modular Medical, Inc. will continue its business operations as disclosed in its other filings.

Key Dates

Keywords

Modular Medical, Solas Capital Management, Frederick Tucker Golden, Schedule 13G, Beneficial Ownership, Warrants, Investment Adviser, Common Stock